Building upon this, Figure 3 presents an integrated mechanistic model highlighting how IGF signaling serves as a pathogenic hub that connects these processes through cell-type-specific effects, modulation by IGFBPs, and crosstalk with other PAH pathways. Here, IGF1 is linked to pulmonary arterial hypertension.